Tadalafil Tablet, Film Coated
Product Images NDC 71335-2467

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 71335-2467). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 01)

Chemical structure of tadalafil shown as a 2D molecular diagram indicating its ring systems and functional groups.*

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 02)

Four line graphs showing blood pressure changes over time comparing tadalafil versus placebo. The charts display standing systolic and diastolic blood pressure, and supine systolic and diastolic blood pressure. The x-axis represents time in hours up to 96, and the y-axis shows the difference in mmHg between tadalafil and placebo readings.*

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 03)

This image contains two line graphs displaying changes in systolic blood pressure (mmHg) over 24 hours post-dose. The top graph shows standing systolic blood pressure and the bottom graph shows supine systolic blood pressure. Both compare the effects of tadalafil 20 mg combined with doxazosin 8 mg versus placebo combined with doxazosin 8 mg.*

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 04)

A line chart showing the change in systolic blood pressure (mmHg) over 12 hours following administration of tadalafil or placebo, combined with doxazosin, measured at two different times (08:00 and 20:00). The x-axis represents time after administration and the y-axis represents systolic blood pressure changes.*

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 05)

A line graph showing plasma tadalafil concentration (micrograms per liter) over time (hours) for three dosing regimens: single 20-mg dose, single 5-mg dose, and once-daily 5-mg dose after 5 consecutive days. The graph includes error bars indicating variability for each data point.*

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 06)

A line graph comparing the change from baseline in IPSS total score over 12 weeks of treatment between tadalafil 5 mg and placebo groups. The x-axis represents the duration of treatment in weeks, and the y-axis shows the change in IPSS total score. The graph indicates a greater reduction in score with tadalafil 5 mg compared to placebo, with statistical significance noted at p<0.01.*

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 07)

A line graph comparing the change from baseline in IPSS total score over 12 weeks between tadalafil 5 mg and placebo. The x-axis represents the duration of treatment in weeks (0, 1, 4, 8, 12), and the y-axis shows the change from baseline in IPSS total score, ranging from 0 to -7. The tadalafil group shows a greater decrease in IPSS scores over time compared to placebo, with a statistical significance noted at week 4 (p < 0.01).*

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 08)

A line graph showing least-squares mean change from baseline over 26 weeks of therapy comparing Tadalafil/Finasteride and Placebo/Finasteride groups. The x-axis represents weeks of therapy (0, 4, 12, 26), and the y-axis shows LS mean change values, with statistically significant differences marked at various points.*

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 09)

A line graph depicting change from baseline in IPSS Total Score over a 12-week treatment duration. The graph compares tadalafil 5 mg and placebo, showing a greater decrease in IPSS Total Score with tadalafil over time. The x-axis represents treatment duration in weeks, and the y-axis shows change from baseline in IPSS Total Score.*

FDA Label Image

Unichem Logo (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 10)

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 11)

FDA Label Image

Label (Lbl713352467)

Tadalafil Tablets, USP 5 mg film-coated oral tablets label from Bryant Ranch Prepack. The label shows the NDC 71335-2467-1, indicates 30 tablets per package, and includes storage instructions and a QR code for dosage information. Manufactured by Unichem Laboratories Ltd.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.